KCT0004447
Not yet recruiting
未知
A 12week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the evaluation of the efficacy and safety of CT20S on the Skin wrinkle improvement
P&K Skin Research Center0 sites120 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- P&K Skin Research Center
- Enrollment
- 120
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Women over 40 years old and under 55 years old
- •2\) In a visual evaluation, both left and right eye wrinkles are grade 3 or higher
- •3\) Using Corneometer®, measure the amount of water in both cheeks. Left and right cheeks are less than 49AU
- •4\) Those who have agreed to participate in this test prior to the start of the test and have signed a written consent form
Exclusion Criteria
- •1\) Those who have or are currently undergoing treatment for skin diseases such as atopic dermatitis and psoriasis
- •2\) Sensitive or allergic to food ingredients for this human application test
- •3\) People with abnormal skin conditions such as spots, acne, erythema, and capillary dilation in the test area
- •4\) Visit 1 A person who received treatment on the facial (skin stripping, other skin care, etc.) or received treatment on the facial area within 6 months
- •5\) Visitor 1 Use a skin external substance containing steroids on the facial part or take an oral retinoid/steroid agent within 3 months of the standard visit
- •6\) Visitor 1 Use functional cosmetic (retinoid agent, retinol, AHA) or moisturizing cosmetic or skin care (LED mask, ion booster, etc.) to improve wrinkles within 2 weeks of visit
- •7\) People who take diet pills (absorbent and antidepressants, appetite suppressants, etc.) and contraceptives or hormones or diuretics within one month based on visit1
- •8\) Visitors who have taken antioxidants, hyaluronic acid, health function foods containing collagen, moon flower species freedom, vitamin A, vitamin C, vitamin E\-containing medicines and health function foods within two weeks of visit1;
- •9\) Visit 1 A person who has participated in other interventional clinical tests (including human application tests) within one month of the standard or plans to participate in other interventional clinical tests (including human application tests) after the start of this human application test.
- •10\) Person whose AST (GOT) or ALT (GPT) is 120IU/L or higher, or whose ?\-GTP is 180IU/L or higher
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical Trial for the evaluation of the efficacy and safety of 7-MEGATM500 on the Skin wrinkle improvementDiseases of the skin and subcutaneous tissueKCT0004592Vitech90
Completed
Not Applicable
A Clinical Trial for the evaluation of the efficacy and safety of RW0117 on dyspepsiaKCT0005265Richwood Trading Company, LTD.100
Recruiting
Not Applicable
The Efficacy and Safety of KD501 on Memory ImprovementKCT0004424Wonkwang University. Iksan Korean Medicine Hospital80
Active, not recruiting
Phase 1
A 12-week Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic GastroparesisEUCTR2017-002177-20-ATAllergan Ltd.311
Active, not recruiting
Phase 1
A 12-week Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic GastroparesisDiabetic GastroparesisMedDRA version: 20.1Level: PTClassification code 10051153Term: Diabetic gastroparesisSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2017-002177-20-ROAllergan Ltd.311